Hongwei Du

2.8k total citations
52 papers, 1.7k citations indexed

About

Hongwei Du is a scholar working on Oncology, Biomedical Engineering and Immunology. According to data from OpenAlex, Hongwei Du has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Biomedical Engineering and 13 papers in Immunology. Recurrent topics in Hongwei Du's work include CAR-T cell therapy research (17 papers), Nanowire Synthesis and Applications (7 papers) and Immunotherapy and Immune Responses (4 papers). Hongwei Du is often cited by papers focused on CAR-T cell therapy research (17 papers), Nanowire Synthesis and Applications (7 papers) and Immunotherapy and Immune Responses (4 papers). Hongwei Du collaborates with scholars based in China, United States and Italy. Hongwei Du's co-authors include Gianpietro Dotti, Barbara Savoldo, Peishun Shou, Yu‐Hui Chen, Chuang Sun, Yang Xu, David H. Olson, Xiaochen Wang, Koichi Hirabayashi and Anton Gartner and has published in prestigious journals such as Science, Nature Communications and Blood.

In The Last Decade

Hongwei Du

46 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongwei Du China 23 825 465 459 438 200 52 1.7k
Tingting Tan China 20 371 0.4× 441 0.9× 220 0.5× 628 1.4× 127 0.6× 44 1.6k
Ying Dong Australia 29 853 1.0× 254 0.5× 542 1.2× 1.5k 3.4× 147 0.7× 70 3.5k
Li Su China 25 394 0.5× 182 0.4× 224 0.5× 895 2.0× 131 0.7× 82 2.0k
Behzad Baradaran Iran 28 757 0.9× 659 1.4× 773 1.7× 1.4k 3.1× 110 0.6× 113 2.9k
P. Louise Coletta United Kingdom 27 298 0.4× 271 0.6× 639 1.4× 582 1.3× 279 1.4× 81 2.2k
Yuxin Lin China 15 491 0.6× 602 1.3× 251 0.5× 779 1.8× 53 0.3× 32 1.9k
Bing Dong China 26 416 0.5× 251 0.5× 133 0.3× 1.1k 2.5× 126 0.6× 93 2.1k
Juanjuan Du China 22 500 0.6× 174 0.4× 694 1.5× 1.1k 2.6× 187 0.9× 52 2.2k
Yikai Zhang China 17 529 0.6× 348 0.7× 80 0.2× 421 1.0× 65 0.3× 52 1.4k
Ronggui Hu China 22 255 0.3× 172 0.4× 370 0.8× 1.1k 2.5× 131 0.7× 56 2.0k

Countries citing papers authored by Hongwei Du

Since Specialization
Citations

This map shows the geographic impact of Hongwei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Du more than expected).

Fields of papers citing papers by Hongwei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Du. The network helps show where Hongwei Du may publish in the future.

Co-authorship network of co-authors of Hongwei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Du. A scholar is included among the top collaborators of Hongwei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Du. Hongwei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Liu, Xin, Yujun Xu, Xiaoguang Xu, et al.. (2025). Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinoma. International Immunopharmacology. 156. 114725–114725. 1 indexed citations
4.
Du, Hongwei, S. Michael Yu, Yuxuan Wang, et al.. (2025). Protocol for embedded 3D bioprinting of arterial models with customized contractile and metabolic functions. STAR Protocols. 6(2). 103820–103820.
5.
Du, Hongwei, S. Michael Yu, Qi Li, et al.. (2025). 3D bioprinted human-scale intestine models for physiological and microbial insights through fluid-driven heterogeneity. Science Advances. 11(47). eady6562–eady6562.
6.
Chen, Yuxin, Lulu Han, Ying Cai, et al.. (2024). Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors. Pharmacological Research. 210. 107506–107506. 2 indexed citations
7.
Li, Huizhong, Fei Wang, Jian Cao, et al.. (2024). Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinoma. Molecular Immunology. 176. 1–10. 1 indexed citations
8.
Zhang, Meishuang, Meishuang Zhang, Hongwei Du, et al.. (2022). Study on the Effect of PDA-PLGA Scaffold Loaded With Islet Cells for Skeletal Muscle Transplantation in the Treatment of Diabetes. Frontiers in Bioengineering and Biotechnology. 10. 927348–927348. 8 indexed citations
9.
Guo, Lu, Zhikun Li, Yuhuan Li, et al.. (2022). Treatment of glutaric aciduria type I (GA-I) via intracerebroventricular delivery of GCDH. Fundamental Research. 2(6). 836–842. 3 indexed citations
10.
Lichtman, Eben I., Hongwei Du, Peishun Shou, et al.. (2021). Preclinical Evaluation of B7-H3–specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia. Clinical Cancer Research. 27(11). 3141–3153. 57 indexed citations
11.
Ma, Xingcong, Peishun Shou, Christof C. Smith, et al.. (2020). Interleukin-23 engineering improves CAR T cell function in solid tumors. Nature Biotechnology. 38(4). 448–459. 197 indexed citations
12.
Nehama, Dean, Natalia Di Ianni, Silvia Musio, et al.. (2019). B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres. EBioMedicine. 47. 33–43. 139 indexed citations
13.
Zhou, Xiaoling, Lili Zheng, Hongwei Du, et al.. (2019). Factors influencing DBPs occurrence in tap water of Jinhua Region in Zhejiang Province, China. Ecotoxicology and Environmental Safety. 171. 813–822. 65 indexed citations
14.
Zhang, Hui, Hui Zhang, Fan Wu, et al.. (2013). The twoC. elegansATG-16 homologs have partially redundant functions in the basal autophagy pathway. Autophagy. 9(12). 1965–1974. 28 indexed citations
15.
Liu, Bin, et al.. (2012). LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis. Science. 337(6092). 351–354. 137 indexed citations
16.
Du, Hongwei, Paul D. Hamilton, Matthew A. Reilly, & Nathan Ravi. (2012). Injectable in situ Physically and Chemically Crosslinkable Gellan Hydrogel. Macromolecular Bioscience. 12(7). 952–961. 39 indexed citations
17.
Sun, Jinying, Hongwei Du, & Tianyan You. (2011). Determination of nicotine and its metabolite cotinine in urine and cigarette samples by capillary electrophoresis coupled with electrochemiluminescence. Electrophoresis. 32(16). 2148–2154. 18 indexed citations
18.
Du, Hongwei, et al.. (2009). A facile synthesis of highly water-soluble, core–shell organo-silica nanoparticles with controllable size via sol–gel process. Journal of Colloid and Interface Science. 340(2). 202–208. 33 indexed citations
19.
Gens, J. Scott, et al.. (2007). Different ionic conditions prompt NHE2 and NHE3 translocation to the plasma membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1768(5). 1023–1035. 9 indexed citations
20.
Du, Hongwei, Hai‐Feng Ji, Xiaohe Xu, et al.. (2006). Organophosphorus hydrolase multilayer modified microcantilevers for organophosphorus detection. Biosensors and Bioelectronics. 22(11). 2636–2642. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026